Petr Kaňovský
Researcher Next ID · RN-041877
Researcher · Medicine
Olomouc, Czechia
- Works count
- 507
- Citation count
- 6,939
- H-index
- 43
- i10-index
- 141
Research interests
Publications
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology · 2018 · https://doi.org/10.1016/s1474-4422(18)30069-3
Summary of the recommendations of the EFNS / MDS ‐ ES review on therapeutic management of P arkinson's disease
European Journal of Neurology · 2012 · https://doi.org/10.1111/j.1468-1331.2012.03866.x
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
European Journal of Neurology · 2006 · https://doi.org/10.1111/j.1468-1331.2006.01547.x
Current projects
No projects listed.